The small molecule inhibitor DCZ0415 targeting TRIP13 has been reported to restrain the multiplication ability of multiple myeloma cells, colorectal cancer cells, pancreatic ductal adenocarcinoma cells, and lung adenocarcinoma cells. Here, TRIP13 is linked to AL amyloidosis.